サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：人工多能性幹細胞（iPSC）市場：由来細胞別、用途別、国別、地域別- 産業分析、市場規模、市場シェア、2023-2030年予測
市場調査レポート
商品コード
1290848

人工多能性幹細胞（iPSC）市場：由来細胞別、用途別、国別、地域別- 産業分析、市場規模、市場シェア、2023-2030年予測

Induced Pluripotent Stem Cell (iPSC) Market with COVID-19 Impact Analysis, By Derived Cell, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 402 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.58円
人工多能性幹細胞（iPSC）市場：由来細胞別、用途別、国別、地域別- 産業分析、市場規模、市場シェア、2023-2030年予測
出版日: 2023年06月01日
発行: AnalystView Market Insights
ページ情報: 英文 402 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

人工多能性幹細胞（iPSC）市場規模は2022年に20億530万米ドルとなり、2023年から2030年にかけてCAGR 7.1％で拡大

人工多能性幹細胞（iPSC）市場-市場力学

特にパンデミックの猛威後のワクチン製造需要の高まり、iPSC分野への投資の増加は、iPSC市場の急成長に寄与する要因の一部です。

パンデミックはまた、疾病治療のための細胞ベースの療法の重要性を強調しています。iPSCは、治療用途に様々な細胞タイプに分化させることができる再生可能な細胞源を提供します。これには、肺障害などのCOVID-19関連合併症を治療するための細胞ベース療法開発へのiPSC利用の可能性も含まれます。世界保健機関によると、慢性閉塞性肺疾患（COPD）は世界第3位の死因であり、2019年には323万人が死亡します。多くの政府がiPSC技術の可能性を認識し、研究と商業化の取り組みを支援するための資金援助プログラムを開始しています。iPSC由来細胞は、ワクチン製造のための一貫したスケーラブルなプラットフォームを提供し、より迅速で効率的なワクチン製造プロセスを可能にします。

人工多能性幹細胞（iPSC）市場-主な洞察

  • 弊社のリサーチアナリストの分析によると、世界の人工多能性幹細胞（iPSC）市場は、予測期間（2023-2030年）において著しく毎年成長すると予測されています。
  • 人工多能性幹細胞（iPSC）産業は、持続可能な成長に対する意識の高まりにより、著しい速度で成長すると予測される
  • タイプ別セグメンテーションでは、心筋細胞が2022年に最大市場シェアを示すと予測される
  • 用途別では、医薬品開発・発見が2022年の主要市場です。
  • 地域別では、北米が2022年に最大の収益源となりました。

人工多能性幹細胞（iPSC）市場-セグメンテーション分析：

世界の人工多能性幹細胞（iPSC）市場は、由来細胞、用途、地域に基づいてセグメント化されます。

市場は由来細胞に基づいて3つのカテゴリーに分けられる：肝細胞、線維芽細胞。肝細胞、線維芽細胞、羊膜細胞、心筋細胞、その他です。心筋細胞が市場を独占しています。患者特異的iPSC由来心筋細胞（iPSC-CMs）は、心血管疾患のモデル化、ヒト発生の初期段階の研究、薬物毒性予測試験の迅速化、潜在的な再生治療の進展のための魅力的な実験プラットフォームを提供します。

市場は用途によって2つのカテゴリーに分けられる：製造、学術研究、医薬品開発・発見、毒性スクリーニング、再生医療です。医薬品開発・探索が市場を独占しており、予測期間中もその優位性は維持されると思われます。人工多能性幹細胞（iPSC）技術は医学に革命をもたらし、疾病メカニズムや新規治療分子標的の探索を可能にし、創薬や医薬品開発における概念実証研究の機会を提供しています。

人工多能性幹細胞（iPSC）市場-地理的洞察

地域的には、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカの各地域に広がっています。北米が人工多能性幹細胞（iPSC）市場を独占すると予想されるのは、慢性疾患の流行とその治療における幹細胞の使用によるものです。Center of Disease Control and Prevention（疾病管理予防センター）によると、2018年には、一般市民の非入院成人の51.8％（1億2900万人）が、選択された10種類の慢性疾患のうち少なくとも1つと診断されています。慢性疾患に対処するための高度な治療法や革新的な治療法に対する需要が、この地域のiPSC市場の成長を牽引しています。全体として、欧州とアジアもiPSCの研究開発に積極的に参加しています。

人工多能性幹細胞（iPSC）市場-競合情勢：

米国、韓国、日本、英国、中国が幹細胞治療のトップ5カ国に浮上したのは、この分野を発展させ、患者に革新的な治療法を提供しようとする姿勢が認められたからです。iPS細胞市場における著名なプレーヤーはほんの一例に過ぎないです。その他の企業、学術機関、研究機関も世界中でiPS細胞の研究、製品開発、臨床試験に積極的に取り組んでいます。例えば、2021年1月27日、サーモフィッシャーサイエンティフィック社は、同種ワークフローを用いた細胞療法開発者向けに、ヒトTリンパ球（T細胞）の開発と増殖のための新しい培地を開発しました。企業が自社のリーチを強化し、市場シェアを拡大するために用いる主な手法には、新製品の発売、流通網の整備、研究開発費、M&Aなどがあります。

最近の動向

2021年11月、ヒトiPS細胞（人工多能性幹細胞）技術のリーディングカンパニーであるNcardia社（ベルギー、ゴセリーズ）は、投資プラットフォームKiniciti社（米国、ニューヨーク）との提携を発表しました。

研究の主な特徴

  • この調査レポートは、人工多能性幹細胞（iPSC）市場の市場規模、CAGR、2022年を基準年とした市場推計・予測（2023-2030年）を提供しています。
  • この調査レポートは、人工多能性幹細胞（iPSC）市場に関する最新動向の洞察を顧客に提供します。
  • この調査レポートは、異なるセグメント/国にわたる潜在的な成長機会を解明し、人工多能性幹細胞（iPSC）市場の魅力的な投資提案マトリクスを説明します。
  • 総合レポートは、人工多能性幹細胞（iPSC）市場における新規投資機会、既存企業が直面する課題、持続的成長要因を明らかにする
  • 人工多能性幹細胞（iPSC）市場規模、予測、CAGR、市場力学に対するCOVID-19の影響は、調査範囲の下で詳細に議論されています。COVID後の人工多能性幹細胞（iPSC）市場に関する詳細な洞察もカバーします。
  • 本レポートのユーザーに人工多能性幹細胞（iPSC）市場の包括的な見解を提供するために、人工多能性幹細胞（iPSC）市場の競合情勢と主要イノベーター分析も含めています。
  • この調査では、成長見通しマッピング分析を網羅し、すべての業界セグメントを市場規模、成長率、魅力度に基づいてベンチマークしています。
  • 本レポートは、人工多能性幹細胞（iPSC）市場で事業を展開する企業の財務情報や戦略的イニシアチブを理解するのに役立つ主要市場参入企業を特集した詳細な企業プロファイルを提供しています。
  • さらに、本レポートは、世界レベルおよび地域レベルでの市場に関与する主要参加者の重要な買収と合併、コラボレーションと合弁事業、新規立ち上げ、研究開発、地域展開も明らかにしています。
  • この調査レポートは、主にサプライヤー、投資家、新規参入者、流通業者、金融アナリストなど、この業界の様々な利害関係者を対象としています。

目次

第1章 人工多能性幹細胞（iPSC）市場概要

  • 調査範囲

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 人工多能性幹細胞（iPSC）の主要な市場動向

  • 市場促進要因の推進力
  • 人工多能性幹細胞（iPSC）市場抑制要因
  • 人工多能性幹細胞（iPSC）の市場機会
  • 人工多能性幹細胞（iPSC）市場の今後の動向

第4章 人工多能性幹細胞（iPSC）産業調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しのマッピング
  • 規制枠組みの分析

第5章 人工多能性幹細胞（iPSC）市場：COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 人工多能性幹細胞（iPSC）市場情勢

  • 人工多能性幹細胞（iPSC）市場シェア分析、2022年
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 人工多能性幹細胞（iPSC）市場- 由来細胞別

  • 概要
    • セグメントシェア分析、由来細胞別
    • 標準的なスチール製人工多能性幹細胞（iPSC）
    • 非磁性誘導多能性幹細胞（iPSC）

第8章 人工多能性幹細胞（iPSC）市場- 用途別

  • 概要
    • 用途別のセグメントシェア分析
    • 陸上
    • オフショア

第9章 人工多能性幹細胞（iPSC）市場-地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の人工多能性幹細胞（iPSC）の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の人工多能性幹細胞（iPSC）主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の人工多能性幹細胞（iPSC）の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの人工多能性幹細胞（iPSC）主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東とアフリカ
    • 概要
    • 中東およびアフリカの人工多能性幹細胞（iPSC）の主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第10章 主要ベンダー分析- 人工多能性幹細胞（iPSC）産業

  • 競合ダッシュボード
  • 企業プロファイル
    • Lonza
    • Axol Biosciences Ltd.
    • Evotec SE
    • Hitachi Ltd.
    • Merck KGaA
    • REPROCELLS, Inc.
    • Fate Therapeutics
    • Thermo Fisher Scientific, Inc.
    • StemCellsFactory III
    • Applied StemCells, Inc.

第11章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Induced Pluripotent Stem Cell (iPSC) Market: Derived cells Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Derived cells
  • TABLE Global Induced Pluripotent Stem Cell (iPSC) Market, by Derived cells 2018-2030 (USD Million)
  • TABLE Induced Pluripotent Stem Cell (iPSC) Market: Application Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Induced Pluripotent Stem Cell (iPSC) Market, by Application 2018-2030 (USD Million)
  • TABLE Induced Pluripotent Stem Cell (iPSC) Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Induced Pluripotent Stem Cell (iPSC) Market, by Region 2018-2030 (USD Million)
  • TABLE North America Induced Pluripotent Stem Cell (iPSC) Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Induced Pluripotent Stem Cell (iPSC) Market, by Derived cells, 2018-2030 (USD Million)
  • TABLE North America Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Induced Pluripotent Stem Cell (iPSC) Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Induced Pluripotent Stem Cell (iPSC) Market, by Derived cells, 2018-2030 (USD Million)
  • TABLE Europe Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Induced Pluripotent Stem Cell (iPSC) Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Induced Pluripotent Stem Cell (iPSC) Market, by Derived cells, 2018-2030 (USD Million)
  • TABLE Asia Pacific Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Induced Pluripotent Stem Cell (iPSC) Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Induced Pluripotent Stem Cell (iPSC) Market, by Derived cells, 2018-2030 (USD Million)
  • TABLE Latin America Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Induced Pluripotent Stem Cell (iPSC) Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Induced Pluripotent Stem Cell (iPSC) Market, by Derived cells, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Induced Pluripotent Stem Cell (iPSC) Market, by Application, 2018-2030 (USD Million)

List of Figures

  • FIGURE Induced Pluripotent Stem Cell (iPSC) Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Derived cells segment market share analysis, 2022 & 2030
  • FIGURE Derived cells segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Application segment market share analysis, 2022 & 2030
  • FIGURE Application segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Technology segment market share analysis, 2022 & 2030
  • FIGURE Technology segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Induced Pluripotent Stem Cell (iPSC) Market share and leading players, 2022
  • FIGURE Europe Induced Pluripotent Stem Cell (iPSC) Market share and leading players, 2022
  • FIGURE Asia Pacific Induced Pluripotent Stem Cell (iPSC) Market share and leading players, 2022
  • FIGURE Latin America Induced Pluripotent Stem Cell (iPSC) Market share and leading players, 2022
  • FIGURE Middle East and Africa Induced Pluripotent Stem Cell (iPSC) Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Induced Pluripotent Stem Cell (iPSC) Market share analysis by country, 2022
  • FIGURE Germany Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Induced Pluripotent Stem Cell (iPSC) Market share analysis by country, 2022
  • FIGURE India Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Induced Pluripotent Stem Cell (iPSC) Market share analysis by country, 2022
  • FIGURE Brazil Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Induced Pluripotent Stem Cell (iPSC) Market share analysis by country, 2022
  • FIGURE Saudi Arabia Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Induced Pluripotent Stem Cell (iPSC) Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
目次
Product Code: ANV1294

REPORT HIGHLIGHT

Induced Pluripotent Stem Cell (iPSC) Market size was valued at USD 2,005.3 million in 2022, expanding at a CAGR of 7.1% from 2023 to 2030.

Induced Pluripotent Stem cells (iPSC) are derived from skin or blood cells that have been reprogrammed back into an embryonic-like pluripotent state that enables the development of an unlimited source of any type of human cell needed for therapeutic purposes. For example, iPSC can be prodded into becoming beta islet cells to treat diabetes, blood cells to create new blood free of cancer cells for a leukemia patient, or neurons to treat neurological disorders. iPSC have certain advantages over other stem cell types in models of regenerative medicine and wound healing. Because they are derived from adult somatic cells, and not embryos, iPSC are not associated with the ethical dilemmas surrounding the use of embryonic stem cells.

Induced Pluripotent Stem Cell (iPSC) Market- Market Dynamics:

Rising demand for vaccine production especially after the onslaught of the pandemic, and increasing investments in the iPSC sector are some of the factors contributing towards rapid iPSC market growth.

The pandemic has also emphasized the importance of cell-based therapies for treating diseases. iPSCs offer a renewable source of cells that can be differentiated into various cell types for therapeutic applications. This includes the potential use of iPSCs for developing cell-based therapies to treat COVID-19-related complications, such as lung damage. According to World health organization, Chronic obstructive pulmonary disease (COPD) is the third leading cause of death worldwide, causing 3.23 million deaths in 2019. Many governments recognize the potential of iPSC technology and have initiated funding programs to support research and commercialization efforts. iPSC-derived cells provide a consistent and scalable platform for vaccine production, enabling faster and more efficient vaccine manufacturing processes.

Induced Pluripotent Stem Cell (iPSC) Market- Key Insights:

  • As per the analysis shared by our research analyst, the global Induced Pluripotent Stem Cell (iPSC) market is estimated to grow annually at a CAGR of around XX% over the forecast period (2023-2030)
  • The Induced Pluripotent Stem Cell (iPSC) industry is projected to grow at a significant rate due to the growing awareness of sustainable growth
  • Based on type segmentation, Cardiomyocytes were predicted to show maximum market share in the year 2022
  • Based on Application segmentation, Drug development, and discovery were the leading in 2022
  • On the basis of region, North America was the leading revenue generator in 2022

Induced Pluripotent Stem Cell (iPSC) Market- Segmentation Analysis:

  • The Global Induced Pluripotent Stem Cell (iPSC) Market is segmented on the basis of derived cells, Application, and Region.
  • The market is divided into three categories based on derived cells: Hepatocytes, Fibroblasts. Amniotic Cells, Cardiomyocytes, and Others. Cardiomyocytes dominate the market. Patient-specific iPSC-derived Cardiomyocytes (iPSC-CMs) offer an attractive experimental platform to model cardiovascular diseases, study the earliest stages of human development, accelerate predictive drug toxicology tests, and advance potential regenerative therapies.
  • The market is divided into two categories based on application: Manufacturing, Academic Research, Drug Development & Discovery, Toxicity Screening, and Regenerative Medicine. Drug development and discovery dominate the market and are likely to maintain its dominance during the forecast period. Induced pluripotent stem cell (iPSC) technology is revolutionizing medical science, allowing the exploration of disease mechanisms and novel therapeutic molecular targets, and offering opportunities for drug discovery and proof-of-concept studies in drug development.

Induced Pluripotent Stem Cell (iPSC) Market- Geographical Insights:

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America is expected to dominate the Induced Pluripotent Stem Cell (iPSC market, due to the prevalence of chronic disease and the use of Stem Cell in their treatment. According to center of disease control and prevention, in 2018, 51.8% (129 million) of civilian, noninstitutionalized adults had been diagnosed with at least 1 of 10 selected chronic conditions. iPSCs hold tremendous potential for developing personalized therapies and disease modeling in these areas. The demand for advanced treatments and innovative therapies to address chronic diseases drives the growth of the iPSC market in this region. Overall, Europe and Asia, are also actively participating in iPSC research and development.

Induced Pluripotent Stem Cell (iPSC) Market- Competitive Landscape:

The United States, South Korea, Japan, the United Kingdom, and China have emerged as the top five countries for stem cell treatment, recognitions to their commitment to advancing the field and providing innovative treatment options for patients. There are just a few examples of prominent players in the iPSC market. Other companies, academic institutions, and research organizations worldwide are actively engaged in iPSC research, product development, and clinical trials. For example, 27 Jan,2021 Thermo Fisher Scientific has developed a new medium for the development and expansion of human T lymphocytes (T-cells) for cell therapy developers using allogeneic workflows. Some of the primary techniques used by corporations to strengthen their reach and expand their market share include new product launches, distribution network development, R&D spending, and mergers and acquisitions.

Recent Developments:

In November 2021, Ncardia (Gosselies, Belgium), a leading human-induced pluripotent stem cell (iPSC) technology company, has recently announced their partnership with investment platform Kiniciti (NY, USA) - a collaboration which will facilitate the development of innovative iPSC-derived advanced therapies.

Key features of the study:

  • This proposed research study on Induced Pluripotent Stem Cell (iPSC) market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year
  • The report provides the client the latest up-to-date and trending insights about the Induced Pluripotent Stem Cell (iPSC) market.
  • The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Induced Pluripotent Stem Cell (iPSC) market
  • The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Induced Pluripotent Stem Cell (iPSC) market
  • Impact of COVID-19 on Induced Pluripotent Stem Cell (iPSC) market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Induced Pluripotent Stem Cell (iPSC) market post-COVID will also be covered.
  • In order to give the users of this report a comprehensive view on the Induced Pluripotent Stem Cell (iPSC) market, we have also included competitive landscape and key innovator analysis for the Induced Pluripotent Stem Cell (iPSC) market.
  • The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
  • The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the Induced Pluripotent Stem Cell (iPSC) market.
  • In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
  • The global Induced Pluripotent Stem Cell (iPSC) market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL INDUCED PLURIPOTENT STEM CELL (IPSC) MARKET KEY PLAYERS

  • Lonza
  • Axol Biosciences Ltd.
  • Evotec SE
  • Hitachi Ltd.
  • Merck KGaA
  • REPROCELLS, Inc.
  • Fate Therapeutics
  • Thermo Fisher Scientific, Inc.
  • StemCellsFactory III
  • Applied StemCells, Inc.

GLOBAL INDUCED PLURIPOTENT STEM CELL (IPSC) MARKET, BY DERIVED CELL

  • Hepatocytes
  • Fibroblasts
  • Amniotic Cells
  • Cardiomyocytes
  • Others

GLOBAL INDUCED PLURIPOTENT STEM CELL (IPSC) MARKET, BY APPLICATION

  • Manufacturing
  • Academic Research
  • Drug Development & Discovery
  • Toxicity Screening
  • Regenerative Medicine

GLOBAL INDUCED PLURIPOTENT STEM CELL (IPSC) MARKET, BY REGION

  • North America
    • The U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • Spain
    • United Kingdom
    • Russia
    • Netherlands
    • Sweden
    • Poland
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • South Korea
    • Japan
    • Australia
    • Thailand
    • Indonesia
    • Philippines
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
    • Rest of LATAM
  • The Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Israel
    • Turkey
    • Algeria
    • Egypt
    • Rest of MEA

Table of Contents

1. Induced Pluripotent Stem Cell (iPSC) Market Overview

  • 1.1. Study Scope

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Induced Pluripotent Stem Cell (iPSC) Market Snippet by Derived Cells
    • 2.1.2. Induced Pluripotent Stem Cell (iPSC) Market Snippet by Application
    • 2.1.3. Induced Pluripotent Stem Cell (iPSC) Market Snippet by Country
    • 2.1.4. Induced Pluripotent Stem Cell (iPSC) Market Snippet by Region
  • 2.2. Competitive Insights

3. Induced Pluripotent Stem Cell (iPSC) Key Market Trends

  • 3.1. Induced Pluripotent Stem Cell (iPSC) Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Induced Pluripotent Stem Cell (iPSC) Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Induced Pluripotent Stem Cell (iPSC) Market Opportunities
  • 3.4. Induced Pluripotent Stem Cell (iPSC) Market Future Trends

4. Induced Pluripotent Stem Cell (iPSC) Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Induced Pluripotent Stem Cell (iPSC) Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Induced Pluripotent Stem Cell (iPSC) Market Landscape

  • 6.1. Induced Pluripotent Stem Cell (iPSC) Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Induced Pluripotent Stem Cell (iPSC) Market - By Derived cells

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Derived cells, 2022 & 2030 (%)
    • 7.1.2. Standard Steel Induced Pluripotent Stem Cell (iPSC)
    • 7.1.3. Non-magnetic Induced Pluripotent Stem Cell (iPSC)

8. Induced Pluripotent Stem Cell (iPSC) Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
    • 8.1.2. Onshore
    • 8.1.3. Offshore

9. Induced Pluripotent Stem Cell (iPSC) Market- By Geography

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. Induced Pluripotent Stem Cell (iPSC) Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.2.6. U.S.
      • 9.2.6.1. Overview
      • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.2.6.3. U.S. Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
      • 9.2.6.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.2.7. Canada
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.2.7.3. Canada Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
      • 9.2.7.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. Induced Pluripotent Stem Cell (iPSC) Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.6. Germany
      • 9.3.6.1. Overview
      • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.6.3. Germany Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
      • 9.3.6.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.7. Italy
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.7.3. Italy Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
      • 9.3.7.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.8. United Kingdom
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.8.3. United Kingdom Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
      • 9.3.8.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.9. France
      • 9.3.9.1. Overview
      • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.9.3. France Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
      • 9.3.9.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.10. Russia
      • 9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.10.2. Russia Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
      • 9.3.10.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.11. Netherlands
      • 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.11.2. Netherlands Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
      • 9.3.11.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.12. Sweden
      • 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.12.2. Sweden Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
      • 9.3.12.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.13. Poland
      • 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.13.2. Poland Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
      • 9.3.13.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.3.14. Rest of Europe
      • 9.3.14.1. Overview
      • 9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.14.3. Rest of the Europe Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
      • 9.3.14.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. Induced Pluripotent Stem Cell (iPSC) Key Manufacturers in Asia Pacific
    • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.4.4. Asia Pacific Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
    • 9.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.6. India
      • 9.4.6.1. Overview
      • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.6.3. India Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
      • 9.4.6.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.7. China
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.7.3. China Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
      • 9.4.7.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.8. Japan
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.8.3. Japan Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
      • 9.4.8.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.9. South Korea
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.9.3. South Korea Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
      • 9.4.9.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.10. Australia
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.10.3. Australia Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
      • 9.4.10.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.11. Thailand
      • 9.4.11.1. Overview
      • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.11.3. Thailand Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
      • 9.4.11.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.12. Indonesia
      • 9.4.12.1. Overview
      • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.12.3. Indonesia Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
      • 9.4.12.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.13. Philippines
      • 9.4.13.1. Overview
      • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.13.3. Philippines Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
      • 9.4.13.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.4.14. Rest of APAC
      • 9.4.14.1. Overview
      • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.14.3. Rest of APAC Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
      • 9.4.14.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.5. Latin America
    • 9.5.1. Overview
    • 9.5.2. Induced Pluripotent Stem Cell (iPSC) Key Manufacturers in Latin America
    • 9.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.5.4. Latin America Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
    • 9.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.6. Brazil
      • 9.5.6.1. Overview
      • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.6.3. Brazil Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
      • 9.5.6.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.7. Mexico
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.7.3. Mexico Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
      • 9.5.7.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.8. Argentina
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.8.3. Argentina Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
      • 9.5.8.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.9. Colombia
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.9.3. Colombia Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
      • 9.5.9.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.5.10. Rest of LATAM
      • 9.5.10.1. Overview
      • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.10.3. Rest of LATAM Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
      • 9.5.10.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Overview
    • 9.6.2. Induced Pluripotent Stem Cell (iPSC) Key Manufacturers in Middle East and Africa
    • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.6.4. Middle East and Africa Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
    • 9.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.6. Saudi Arabia
      • 9.6.6.1. Overview
      • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
      • 9.6.6.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.7. United Arab Emirates
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.7.3. United Arab Emirates Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
      • 9.6.7.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.8. Israel
      • 9.6.8.1. Overview
      • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.8.3. Israel Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
      • 9.6.8.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.9. Turkey
      • 9.6.9.1. Overview
      • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.9.3. Turkey Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
      • 9.6.9.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.10. Algeria
      • 9.6.10.1. Overview
      • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.10.3. Algeria Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
      • 9.6.10.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.11. Egypt
      • 9.6.11.1. Overview
      • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.11.3. Egypt Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
      • 9.6.11.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 9.6.12. Rest of MEA
      • 9.6.12.1. Overview
      • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.12.3. Rest of MEA Market Size and Forecast, By Derived cells, 2018 - 2030 (US$ Million)
      • 9.6.12.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)

10. Key Vendor Analysis- Induced Pluripotent Stem Cell (iPSC) Industry

  • 10.1. Competitive Dashboard
  • 10.2. Company Profiles
    • 10.2.1. Lonza
    • 10.2.2. Axol Biosciences Ltd.
    • 10.2.3. Evotec SE
    • 10.2.4. Hitachi Ltd.
    • 10.2.5. Merck KGaA
    • 10.2.6. REPROCELLS, Inc.
    • 10.2.7. Fate Therapeutics
    • 10.2.8. Thermo Fisher Scientific, Inc.
    • 10.2.9. StemCellsFactory III
    • 10.2.10. Applied StemCells, Inc.

11. 360 Degree Analyst View

12. Appendix

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us